Related Experiment Video

Updated: Apr 16, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
13:36

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches

Published on: May 6, 2015

10.9K

Ebola vaccines based on adenovirus vectors and risk of HIV

Eric J Kremer1, Philippe Van de Perre2

  • 1Institut de Génétique Moléculaire de Montpellier, Université Montpellier; INSERM U 1058, CHU 34293 Montpelier, France eric.kremer@igmm.cnrs.fr.

BMJ (Clinical Research Ed.)
|March 12, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

37.2K
Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting08:14

Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting

Published on: October 26, 2018

9.0K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
34.0K